Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44:4043–140.

Article  CAS  PubMed  Google Scholar 

Ma C-X, Ma X-N, Guan C-H, Li Y-D, Mauricio D, Fu S-B. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21:74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes Mellitus and Cardiovascular Disease: genetic and epigenetic links. Front Endocrinol (Lausanne). 2018;9:2.

Article  PubMed  Google Scholar 

Patsouras A, Farmaki P, Garmpi A, Damaskos C, Garmpis N, Mantas D, et al. Screening and Risk Assessment of Coronary Artery Disease in patients with type 2 diabetes: an updated review. Vivo (Brooklyn). 2019;33:1039–49.

Article  CAS  Google Scholar 

Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: Cardiovascular Disease in Diabetes Mellitus: atherosclerotic Cardiovascular Disease and Heart failure in type 2 diabetes Mellitus - mechanisms, Management, and clinical considerations. Circulation. 2016;133:2459–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park G-M, Lee S-W, Cho Y-R, Kim CJ, Cho JS, Park M-W, et al. Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol. 2014;113:765–71.

Article  PubMed  Google Scholar 

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77.

Article  PubMed  Google Scholar 

Bertolone DT, Gallinoro E, Esposito G, Paolisso P, Bermpeis K, De Colle C, et al. Contemporary management of stable coronary artery disease. High Blood Press Cardiovasc Prev. 2022;29:207–19.

Article  PubMed  PubMed Central  Google Scholar 

Saraste A, Knuuti J. ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: recommendations for cardiovascular imaging. Herz. 2020;45:409–20.

Article  PubMed  PubMed Central  Google Scholar 

Stefanini GG, Windecker S. Can coronary computed tomography angiography replace invasive angiography? Coronary computed tomography angiography cannot replace invasive angiography. Circulation. 2015;131:418–26.

Article  PubMed  Google Scholar 

Yao Q, Chen Y, Zhou X. The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol. 2019;51:11–7.

Article  CAS  PubMed  Google Scholar 

Backes C, Meese E, Keller A. Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects. Mol Diagn Ther. 2016;20:509–18.

Article  CAS  PubMed  Google Scholar 

O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.

Article  PubMed  Google Scholar 

Szydełko J, Matyjaszek-Matuszek B. MicroRNAs as biomarkers for coronary artery disease related to type 2 diabetes Mellitus—from pathogenesis to potential clinical application. Int J Mol Sci. 2023;24:616.

Article  Google Scholar 

Wang W-Y, Zheng Y-S, Li Z-G, Cui Y-M, Jiang J-C. MiR-92a contributes to the cardiovascular disease development in diabetes mellitus through NF-κB and downstream inflammatory pathways. Eur Rev Med Pharmacol Sci. 2019;23:3070–9.

PubMed  Google Scholar 

Al-Kafaji G, Al-Mahroos G, Abdulla Al-Muhtaresh H, Sabry MA, Abdul Razzak R, Salem AH. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients. Biomarkers. 2017;22:268–78.

Article  CAS  PubMed  Google Scholar 

Amr KS, Abdelmawgoud H, Ali ZY, Shehata S, Raslan HM. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease. Br J Biomed Sci. 2018;75:82–7.

Article  CAS  PubMed  Google Scholar 

Seleem M, Shabayek M, Ewida HA. MicroRNAs 342 and 450 together with NOX-4 activity and their association with coronary artery disease in diabetes. Diabetes Metab Res Rev. 2019;35:e3130.

Article  PubMed  Google Scholar 

Luo M, Wang G, Xu C, Zeng M, Lin F, Wu J, et al. Circulating miR-30c as a predictive biomarker of type 2 diabetes mellitus with coronary heart disease by regulating PAI-1/VN interactions. Life Sci. 2019;239:117092.

Article  CAS  PubMed  Google Scholar 

American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of Care in Diabetes—2024. Diabetes Care. 2024;47:S20–42.

Article  Google Scholar 

Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice guidelines. Circulation. 2023;148:e9–119.

Article  PubMed  Google Scholar 

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.

Article  CAS  PubMed  Google Scholar 

Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43:W460–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, et al. The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42:e133.

Article  PubMed  PubMed Central  Google Scholar 

Fan Y, Xia J. miRNet—Functional Analysis and Visual Exploration of miRNA–Target interactions in a Network Context. Methods Mol Biol. 2018;1819:215–33.

Article  CAS  PubMed  Google Scholar 

Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J Proteome Res. 2019;18:623–32.

Article  CAS  PubMed  Google Scholar 

Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.

Article  PubMed  PubMed Central  Google Scholar 

Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.

Article  PubMed  PubMed Central  Google Scholar 

Sondermeijer BM, Bakker A, Halliani A, de Ronde MW, Marquart AA, Tijsen AJ, et al. Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*. PLoS ONE. 2011;6:e25946.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang Y-Z, Dong J, Zhang J, Wang S, He Y, Yan Y-X. Identification of neuroendocrine stress response-related circulating MicroRNAs as biomarkers for type 2 diabetes Mellitus and insulin resistance. Front Endocrinol (Lausanne). 2018;9:132.

Article  PubMed  Google Scholar 

Yan S, Wang T, Huang S, Di Y, Huang Y, Liu X, et al. Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes. Acta Diabeto